CoverageForm 410-K10-Q8-K13D13G13F

CHPM · Chp Merger Corp. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemFY 2021FY 2020
Revenue--
Cost of Revenue--
Gross Profit--
R&D--
SG&A$3.61M$651.4K
Total Operating Expenses--
D&A--
Operating Income($3.61M)($651.4K)
Interest Expense--
Income Tax$0$375.1K
Net Income$22.22M$959.9K
EPS - Basic--
EPS - Diluted--

Balance Sheet

Line itemFY 2021FY 2020
Cash & Equivalents$98.6K$604.2K
Accounts Receivable--
Inventory--
Accounts Payable--
Current Assets$401.2K$604.2K
Total Assets$188.79M$302.93M
Current Liabilities$4.25M$335.2K
Long-term Debt--
Total Liabilities$25.70M$10.84M
Stockholders' Equity($24.26M)($25.84M)
Retained Earnings($24.26M)($634.8K)

Cash Flow

Line itemFY 2021FY 2020
Operating Cash Flow($1.77M)($781.8K)
Investing Cash Flow$114.01M$84.4K
Financing Cash Flow($112.74M)$0
CapEx--
Free Cash Flow--

Ratios

MetricFY 2021FY 2020
Profitability
Gross margin--
Operating margin--
EBITDA margin--
Net margin--
Free cash flow margin--
FCF / Net income--
R&D / Revenue--
SG&A / Revenue--
Effective tax rate0.0%28.1%
Return on assets11.8%0.3%
Return on equity-91.6%-3.7%
Return on invested capital--
Liquidity
Current ratio0.091.80
Quick ratio0.091.80
Cash ratio0.021.80
Leverage
Debt / Equity--
Debt / Assets--
Debt / EBITDA--
Interest coverage--
Equity multiplier-7.78-11.72
Liabilities / Assets0.140.04
Efficiency
Asset turnover--
Inventory turnover--
Days sales outstanding--
Days inventory outstanding--
Days payable outstanding--
Cash conversion cycle--
Valuation
P / E--
P / B--
P / S--
EV / EBITDA--
Growth
Revenue growth (YoY)--
Revenue CAGR (3y)--
Revenue CAGR (5y)--
Gross profit growth (YoY)--
Operating income growth (YoY)-453.5%-
Net income growth (YoY)2214.7%-
EPS growth (YoY)--
EPS CAGR (3y)--
EPS CAGR (5y)--
FCF growth (YoY)--
FCF CAGR (5y)--
Book value growth (YoY)6.1%-

Stability scores

Piotroski F-score

FY 2021 · 9-point quality

2/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • -Long-term debt decreased
  • Current ratio improved
  • -No share dilution
  • -Gross margin improved
  • -Asset turnover improved

Peer comparison

Same SIC group: Surgical & Medical Instruments & Apparatus

CompanyRevenue (last FY)Net marginROE
BSX$20.07B14.4%12.0%
LMAT$249.60M23.1%14.7%
TNDM$1.01B-20.2%-131.9%
SYK$25.12B12.9%14.5%
MMM$24.95B13.0%69.1%

Comparing CHP Merger Corp. against the 5 most active filers in the same SIC group.